FTC to Investigate PBMs’ Impact on Prescription Drug Access, Affordability
- June 10, 2022
The Federal Trade Commission (FTC) is launching an investigation of pharmacy benefit managers’ (PBMs’) practices to shed more light on the industry, which has drawn increased scrutiny in recent years amid rising drug costs.
ARTICLE TAGS
You must be logged in to access this content.